English

Navamedic ASA Q2 2015 Report

Report this content

After the end of the quarter Navamedic acquired the Swedish medtech company Observe Medical International AB, which has developed the next generation digital urine meter for use in intensive care, Sippi®. The innovative, patent protected product has secured distribution in Germany and the Nordic markets and holds global sales potential in a market worth approximately two Bn NOK, Navamedic expects a strong future sales growth for Sippi®

Navamedic's revenues in the second quarter 2015 were in line with the same quarter last year, while sales for the first half of the year saw a 19% growth compared to previous year.

Profitability compared to previous year improved, in the second quarter as well as year to date. Inventories were reduced, and cash flow from operations improved considerably.


Contact Navamedic ASA:

CEO Tom Rönnlund
E-mail: tom.ronnlund@navamedic.com 
Mobile +46 727 320 321

CFO Bjørn Lindholt
E-mail: bjorn.lindholt@navamedic.com
Mobile: +47 93 00 66 01 


 This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Subscribe

Documents & Links